Identification of the Novel HLA‐C*03:689 Allele by Sanger Dideoxy Nucleotide Sequencing
HLA · 2025
DOI: 10.1111/tan.70105 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Yu Jie Wen und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Laboratory, Beijing Red Cross Blood Center, Beijing, China. Hauptthemen laut MEDLINE: Alleles, Exons, Sequence Analysis, DNA, HLA-C Antigens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben. Gefördert von: Beijing Red Cross Blood Center Research Funds.
Abstract (Originalsprache)
The novel HLA‐C*03:689 allele differs from HLA‐C*03:03:01:01 by two nucleotide substitutions in codons 81 and 82 in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Laboratory, Beijing Red Cross Blood Center, Beijing, China.
ORCID-Profile: Yu Jie Wen
Förderung
- Beijing Red Cross Blood Center Research Funds
Zitieren
APA
Wen, Y. J., Fan, C. Y., Liu, N., Wang, J., & Sun, T. C. (2025). Identification of the Novel HLA‐C*03:689 Allele by Sanger Dideoxy Nucleotide Sequencing. HLA. https://doi.org/10.1111/tan.70105
Vancouver
Wen YJ, Fan CY, Liu N, Wang J, Sun TC. Identification of the Novel HLA‐C*03:689 Allele by Sanger Dideoxy Nucleotide Sequencing. HLA. 2025. doi:10.1111/tan.70105
BibTeX
@article{Wen2025,
author = {Wen, Yu Jie and Fan, Cheng Yan and Liu, Na and Wang, Jie and Sun, Tie Cheng},
title = {Identification of the Novel HLA‐C*03:689 Allele by Sanger Dideoxy Nucleotide Sequencing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70105}
}
EUVIMED